In CRC, the overexpression of DEGS2, a key ceramide‐synthesizing enzyme, results in the inhibition of ceramide synthesis and the proliferation and migration of CRC cells through reduced m6A modification of METTL3 and YTHDF2.411. This evidence concerns the gene METTL3 and colorectal carcinoma.